Anti-infective therapies encompass a diverse array of treatments designed to combat microbial infections and improve patient outcomes. Antibiotics, a cornerstone of these therapies, target bacterial infections through various mechanisms, disrupting bacterial cell walls or inhibiting protein synthesis. Antiviral medications are vital in managing viral infections, with drugs like acyclovir and ritonavir inhibiting the replication of viruses such as herpes and HIV. Antifungal agents like amphotericin B address fungal infections, crucial in scenarios like systemic candidiasis. Combating emerging infectious diseases often requires a multifaceted approach. Vaccines, a proactive form of anti-infective therapy, stimulate the immune system to recognize and neutralize pathogens, preventing infections. Additionally, advancements in immunomodulatory drugs contribute to enhancing the body's natural defense mechanisms against infections. As the landscape of infectious diseases evolves, ongoing research strives to develop innovative anti-infective therapies, emphasizing the importance of a dynamic and adaptable approach to disease management.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Detection and variant characterization of lumpy skin disease virus (LSDV) from dairy cattle in India
Manali Bajpai, CSIR-National Chemical Laboratory, India
Title : Acceptability of mass drug administration for lymphatic filariasis in Baglung municipality of Nepal: A mixed-method study
Muskan Pudasainee, Pokhara University, Nepal